Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival
Alex Agelidis, Benjamin A. Turturice, Rahul K. Suryawanshi, Tejabhiram Yadavalli, Dinesh Jaishankar, Joshua Ames, James Hopkins, Lulia Koujah, Chandrashekhar D. Patil, Satvik R. Hadigal, Evan J. Kyzar, Anaamika Campeau, Jacob M. Wozniak, David J. Gonzalez, Israel Vlodavsky, Jin-ping Li, David L. Perkins, Patricia W. Finn, Deepak Shukla
Alex Agelidis, Benjamin A. Turturice, Rahul K. Suryawanshi, Tejabhiram Yadavalli, Dinesh Jaishankar, Joshua Ames, James Hopkins, Lulia Koujah, Chandrashekhar D. Patil, Satvik R. Hadigal, Evan J. Kyzar, Anaamika Campeau, Jacob M. Wozniak, David J. Gonzalez, Israel Vlodavsky, Jin-ping Li, David L. Perkins, Patricia W. Finn, Deepak Shukla
View: Text | PDF
Research Article Cell biology Microbiology

Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival

  • Text
  • PDF
Abstract

The drive to withstand environmental stresses and defend against invasion is a universal trait extant in all forms of life. While numerous canonical signaling cascades have been characterized in detail, it remains unclear how these pathways interface to generate coordinated responses to diverse stimuli. To dissect these connections, we followed heparanase (HPSE), a protein best known for its endoglycosidic activity at the extracellular matrix but recently recognized to drive various forms of late-stage disease through unknown mechanisms. Using herpes simplex virus-1 (HSV-1) infection as a model cellular perturbation, we demonstrate that HPSE acts beyond its established enzymatic role to restrict multiple forms of cell-intrinsic defense and facilitate host cell reprogramming by the invading pathogen. We reveal that cells devoid of HPSE are innately resistant to infection and counteract viral takeover through multiple amplified defense mechanisms. With a unique grasp of the fundamental processes of transcriptional regulation and cell death, HPSE represents a potent cellular intersection with broad therapeutic potential.

Authors

Alex Agelidis, Benjamin A. Turturice, Rahul K. Suryawanshi, Tejabhiram Yadavalli, Dinesh Jaishankar, Joshua Ames, James Hopkins, Lulia Koujah, Chandrashekhar D. Patil, Satvik R. Hadigal, Evan J. Kyzar, Anaamika Campeau, Jacob M. Wozniak, David J. Gonzalez, Israel Vlodavsky, Jin-ping Li, David L. Perkins, Patricia W. Finn, Deepak Shukla

×

Figure 4

Deletion of HPSE protects against cellular infiltration and associated inflammation in a murine model of corneal infection.

Options: View larger image (or click on image) Download as PowerPoint
Deletion of HPSE protects against cellular infiltration and associated i...
(A) HSV-1 titers 2 days following corneal infection of Hpse+/+ and Hpse-/- mice (n = 44). Significance determined by Wilcoxon signed-rank test. (B–D) Markedly decreased corneal inflammation and infiltration (arrowhead) in Hpse-deficient mice 14 days following HSV-1 infection observed by gross imaging (B), H&E histology (C), and flow cytometry of dissociated corneal tissues (D). Scale bars: 1 mm (B), 50 μm (C). (E) Quantification of leukocytes (CD45+) present in corneal tissue at indicated dpi as observed by flow cytometry (n = 5 for infected animals, n = 3 for uninfected animals). Significance determined by 2-way ANOVA with Sidak correction for multiple comparisons. (F) Corneal IFN-β mRNA copy number relative to β-actin measured at 2 dpi (n = 10). Uninfected (ui) samples constituted 2 pools of 5 mouse corneas each. Significance determined by 2-way ANOVA with Sidak correction for multiple comparisons. (G–J) Partial restoration of viral titers and cellular infiltration in HPSE-deficient mice after topical application of α-IFNAR monoclonal antibody, observed by ocular wash titers (G), gross analysis of ipsilateral draining lymph nodes (DLN) (H), and gross analysis (I) and scoring (J) of corneal opacity (n = 4). Scale bar: 1 mm. Data represent mean ± SEM. Significance determined by unpaired t test unless otherwise specified. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts